Home › Non-Small Cell Lung Cancer › California › Glendale
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Glendale, CA
9 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Glendale (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Nagre-recruitPhase 2/3
- Los Angeles Cancer Network, Glendale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Oncura Health - Corporate (Central IDS & Regulatory Only), Glendale
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 2
- Los Angeles Cancer Network, Glendale
- Glendale Adventist Medical Center, Glendale
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
- OPN Healthcare, Inc, Glendale
Pan-tumor MRD Study
Nagre-recruitObservasyonal na pag-aaral
- Los Angeles Cancer Network (LACN), Glendale
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Nagre-recruitPhase 3
- Oncura Health d.b.a.Los Angeles Cancer Network, Glendale
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Nagre-recruitPhase 3
- OPN Healthcare, Inc., Glendale
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
- Los Angeles Cancer Network, Glendale
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Nagre-recruitPhase 2
- OPN Healthcare, Inc., Glendale
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Glendale
- Major Depressive Disorder12 pag-aaral
- Depression6 pag-aaral
- Kanser (lahat ng uri)5 pag-aaral
- Obesity5 pag-aaral
- Kanser sa Suso4 pag-aaral
- Colorectal Cancer4 pag-aaral
- Kanser sa Baga4 pag-aaral
- Metastatic Cancer3 pag-aaral
- Sakit sa Coronary Artery3 pag-aaral
- Melanoma3 pag-aaral
- Edema sa Macula3 pag-aaral
- Overweight3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.